The XJO is expected to edge lower on open this morning despite a small rise from the U.S overnight. Our meek open may be put down to a few reasons. Firstly, U.S futures have edged into the red. Secondly, we managed to hold our gains yesterday despite a pullback in the U.S the night before,
Read More
In 2023, cancer is responsible for about three in 10 deaths across Australia. And among women, breast cancer remains the most commonly diagnosed. Over two million women worldwide are diagnosed with breast cancer annually, and approximately 20% of them are diagnosed with HER2+ (human epidermal growth factor receptor 2) breast cancer. The growing ageing population
Read More
After ousting Anthony Nantes as CEO in August 2023 (and subsequently seeing John Nantes depart as Chairman), consumer lending company Wisr (ASX: WZR) has been on a cost management journey, trying to regain shareholders’ faith. In the face of its declining loan book balance and revenue, the Company has established the pricing for its fourth
Read More
A healthcare policy change passed in France is likely to see the country quickly targeted by medicinal cannabis companies with Little Green Pharma (ASX: LGP) quick to confirm their plans to increase product distribution to the country thanks to newly favourable healthcare legislation. The recent amendment to the Projet de loi de financement de la
Read More
The XJO is expected to open lower this morning after a tumultuous night of trading in the U.S overnight. Their futures have edged into the green. Our market isn’t likely to be inspired today as the U.S quite clearly rebounded intraday from both their key resistance and yearly highs overnight to finish marginally in the
Read More
Global Markets Update US markets: US markets were stronger, with the Dow Jones up +8.8% and S&P500 up +8.9%, as dovish comments from several Fed officials following weak economic data saw swaps pricing in a 50% chance of a U.S. rate cut in March with the effective fed funds rate to fall to about 4.06%
Read More